Amoéba S.A. (EPA:ALMIB)

Market Cap	66.65M
Revenue (ttm)	601.60K
Net Income (ttm)	-6.59M
Shares Out	49.63M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,550,758
Average Volume	660,861
Open	1.420
Previous Close	1.343
Day's Range	1.278 - 1.444
52-Week Range	0.390 - 1.444
Beta	0.60
RSI	69.84
Earnings Date	Jun 24, 2025

About Amoéba

Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water, crop protection and health sectors. It develops applications using amoeba Willaertia magna C2c Maky. The company was incorporated in 2010 and is based in Chassieu, France.

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2010
• Employees: 20
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMIB

Financial Performance

In 2024, Amoéba's revenue was 601,600, a decrease of -9.44% compared to the previous year's 664,310. Losses were -6.59 million, -53.90% less than in 2023.